Comparison of immediate hypersensitivity reactions to preoperative antibiotics in patients labeled as penicillin allergic

Surgery ◽  
2021 ◽  
Author(s):  
Spencer Fosnot ◽  
Katelyn Currier ◽  
Jay Pendell ◽  
Meghan N. Jeffres
Keyword(s):  
Hypersensitivity Reactions ◽  
Immediate Hypersensitivity ◽  
Preoperative Antibiotics

Delayed and immediate hypersensitivity reactions associated with the use of amalgam

BDJ ◽  
2000 ◽  
Vol 188 (2) ◽  
pp. 73-76 ◽  
Author(s):  
B McGivern ◽  
M Pemberton ◽  
E D Theaker ◽  
J A G Buchanan ◽  
M H Thornhill
Keyword(s):  
Hypersensitivity Reactions ◽  
Immediate Hypersensitivity

scholarly journals Safety Assessment of Hydrolyzed Wheat Protein and Hydrolyzed Wheat Gluten as Used in Cosmetics

2018 ◽  
Vol 37 (1_suppl) ◽  
pp. 55S-66S ◽  
Author(s):  
Christina Burnett ◽  
Wilma F. Bergfeld ◽  
Donald V. Belsito ◽  
Ronald A. Hill ◽  
Curtis D. Klaassen ◽  
...  
Keyword(s):  
Safety Assessment ◽  
Expert Panel ◽  
Average Molecular Weight ◽  
Wheat Gluten ◽  
Safety Data ◽  
Hypersensitivity Reactions ◽  
Wheat Protein ◽  
Laboratory Studies ◽  
Immediate Hypersensitivity

The Cosmetic Ingredient Review (CIR) Expert Panel (Panel) reviewed the product use, formulation, and safety data on hydrolyzed wheat protein and hydrolyzed wheat gluten, which function as skin- and hair-conditioning agents. The Panel determined that data from clinical and laboratory studies were sufficient to demonstrate that these ingredients will not elicit type 1 immediate hypersensitivity reactions in sensitized individuals and will not induce sensitization when the polypeptide lengths of the hydrolysates do not exceed 30 amino acids. The Panel concluded that hydrolyzed wheat gluten and hydrolyzed wheat protein are safe for use in cosmetics when formulated to restrict peptides to an average molecular weight of 3,500 Da or less.

Lung volumes after antigen infusion in the guinea pig in vivo: effects of vagal section

1978 ◽  
Vol 45 (6) ◽  
pp. 957-961 ◽  
Author(s):  
J. M. Drazen ◽  
S. H. Loring ◽  
C. Venugopalan
Keyword(s):  
Total Lung Capacity ◽  
Hypersensitivity Reactions ◽  
Immediate Hypersensitivity ◽  
Similar Extent ◽  
Static Compliance ◽  
Lung Volumes ◽  
Lung Capacity ◽  
In Vivo Effects ◽  
Gas Volume

The effects of intravenous antigen infusion on lung volumes and quasi-static deflationary pulmonary compliance in guinea pigs previously sensitized to ovalbumin were studied in vivo. Ovalbumin infusion significantly increased minimal gas volume to a similar extent in animals with intact or cut vagi. Total lung capacity fell only in animals with intact vagi. Quasi-static compliance fell in both groups of animals, but the fall was significantly greater in animals with intact vagi. These data demonstrate that immediate hypersensitivity reactions alter lung volumes and the elastic properties of the lung by both vagal dependent and vagal independent mechanisms.

scholarly journals Successful olaparib desensitization using a novel one-day protocol

2020 ◽  
Vol 16 (1) ◽  
Author(s):  
Rongbo Zhu ◽  
Stephen Welch ◽  
Hannah Roberts
Keyword(s):  
Adverse Reactions ◽  
Chemotherapeutic Agents ◽  
Hypersensitivity Reactions ◽  
Immediate Hypersensitivity ◽  
Case Presentation ◽  
Tablet Form ◽  
Desensitization Protocol ◽  
Ige Mediated ◽  
Loss Of Tolerance

Abstract Background Olaparib is a revolutionary treatment for patients with ovarian and breast cancer. Currently, there is no established 1-day drug desensitization protocol for patients with olaparib type-1 hypersensitivity reactions despite well documented IgE-mediated adverse reactions occurring with olaparib. Case presentation We report a 58-year-old female with immediate, reproducible IgE-mediated adverse reactions to olaparib tablets with implementation of a 1-day novel desensitization protocol to olaparib. Following desensitization, the patient was successfully transitioned from olaparib capsules to tablets with no loss of tolerance. Conclusions To our knowledge, this is the first reported case of successful olaparib desensitization using a novel 1-day desensitization protocol, and will contribute to drug allergy knowledge, in an area where robust data is lacking. This case demonstrates the important role for drug desensitization in patients with immediate hypersensitivity reactions to chemotherapeutic agents. Furthermore, as olaparib capsules are being phased out in favour of olaparib tablets, we provide a clear case that transitioning from capsule to tablet form did not cause a loss of tolerance.

Sign in / Sign up

Export Citation Format

Share Document